Methods and systems for identifying mechanisms of action of drugs using network dysregulation
A technology of mechanism of action and pharmacological effects, applied in biological systems, biostatistics, bioinformatics, etc., can solve problems that are not suitable for genome-wide analysis and are impractical
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0040] Example: DeMAND
[0041] Given the potential for a candidate gene product G (i.e., its regulator) including transcriptional, signaling, and protein-complex-related interactions interaction, if G belongs to the MoA of the compound, it can be assumed that the activity of the compound will deregulate its regulon. Thus, such dysregulation can be assessed by measuring changes in the joint probability density p(G,G') of gene expression between pairwise regulator interactions. This can capture the direct effect of the compound on the modulation of candidate MoA gene expression and interaction partner expression through direct or indirect regulatory mechanisms (eg, feedback loops).
[0042] For example, consider a candidate MoA gene product G that regulates a set of transcriptional targets. Targeted inhibitors will significantly alter the joint expression probability density of G and its target, since the expression of the latter will be affected, while the expression of G i...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


